Literature for peptidase S01.231: urokinase-type plasminogen activator

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Mutation. To remove the filter click here. See explanation.)

    2010
  1. Paterson,A.D., Rommens,J.M., Bharaj,B., Blavignac,J., Wong,I., Diamandis,M., Waye,J.S., Rivard,G.E. and Hayward,C.P.
    Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene
    Blood115, 1264-1266. PubMed  Europe PubMed DOI  M
  2. 2007
  3. Pesaresi,M., Batelli,S., Prato,F., Polito,L., Lovati,C., Scarpini,E., Quadri,P., Mariani,C., Albani,D. and Forloni,G.
    The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
    Neurobiol Dis25, 609-613. PubMed  Europe PubMed DOI  M
  4. 2003
  5. Beqaj,S.H., Post,D. and Ryan,J.M.
    Single-nucleotide polymorphism of the urokinase-plasminogen activator gene during aging and transformation of human diploid kidney cell cultures
    In Vitro Cell Dev Biol Anim39, 343-347. PubMed  Europe PubMed DOI  M